ArticleBritish journal of cancer2023

Pathological complete response, category change, and prognostic significance of HER2-low breast cancer receiving neoadjuvant treatment: a multicenter analysis of 2489 cases.

Siji Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.